Chinese General Practice ›› 2025, Vol. 28 ›› Issue (05): 639-648.DOI: 10.12114/j.issn.1007-9572.2024.0295
Special Issue: 阿尔茨海默病最新文章合辑; 中医最新文章合辑
• Review & Perspectives • Previous Articles
Received:
2024-07-10
Revised:
2024-08-25
Published:
2025-02-15
Online:
2024-11-25
Contact:
LIU Bin
通讯作者:
刘斌
作者简介:
作者贡献:
裴金英提出研究命题,进行文章的构思与撰写;宋金洲、马到丰进行文献的检索与收集;罗孝廷、董晓红、丛树园进行论文修订;刘斌负责文章的质量控制及审校,并对文章整体负责。
基金资助:
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0295
有效成分 | 模型 | 剂量 | 靶点 |
---|---|---|---|
红景天苷 | SAMP8小鼠 | 30 mg/kg | Aβ1-42、铁沉积、MDA、IL-1β、IFN-γ、TNF-α、ACSL4、TFR1↓、GSH、SOD、IL-10、GPX4、SLC7A11、SLC3A2、FTH1、Fpn1、Nrf2、HO-1↑ |
Nrf2基因敲除小鼠、C57BL/6小鼠 | 50 mg/kg | MDA↓、SOD↑、GSH/GSSG↑、GPX4↑、SLC7A11↑、HO-1↑、ROS↓、Nrf2↑、Fe2+↓、PTGS2↓ | |
连翘酯苷A | APP/PS1小鼠 | 30 mg/kg | MDA↓、MMP,Aβ1-42、p-tau、NO↓、IL-4↑、IL-10↑、IL-1β↓、IL-6↓、Fe、GPX4↑、xCT↑、FTL↑、Fpn↑、DRD1↑、CREB↑、BDNF↑、TrkB↑、PI3K、p-AKT、GNAL↑、Adcy5↑、cAMP↑、p-Fyn↓、p-GSK-3β↑、Nrf2↑、TFRC↓、DMT1↓、FTH↑、Iba1↓、GFAP↓、TGF-β↑、MCP-1↓、ALOX5↓、CD33↓、iNOS↓、TNF-α↓、IKK↓ |
芍药苷 | C57BL/6小鼠、APP/PS1小鼠 | 10 mg/kg | Fe3+↓、SOD↑、MDA↓、JC-1↑、P53↓、STAT3、GPX4↑、GAPDH、ΔΨm |
淫羊藿苷 | APP/PS1小鼠、C57BL/6小鼠 | 5、10 mg/kg | MDA↓、SOD↑、MDM2、GSH-Px↑、LDH↓、GSH↑、caspase-3↓、Fe↓、p53↓、Aβ25-35↓、p-Tau |
何首乌苷 | APP/PS1小鼠、C57BL/6小鼠 | 60、120、180 mg/kg | Aβ↓、GSS、SOD1、SOD2、Prdx1、8-OHdG↓、Nrf2↑、Keap1↑、HO-1↑、NQO1↑、GCLC↑、GCLM↑、NLRP3↓、TXNIP↓、TXNRD1↓、iNOS↓、GPX4↑、xCT、GPX4↑、GPX1↑、FTH1↑、xCT↑、CD98↑、DMT1↓、ACSL4↓、NCOA4↓、FTH↓、FTL↓ |
远志皂苷元 | Aβ25-35诱导的PC12细胞 | 15、30、60、120、240 μmol/L | ACSL4↓、PEBP1↓、GPX4↑、ROS↓、MDA、GAPDH |
细叶远志皂苷 | C57BL/6小鼠 | 10 mg/kg | AKT、STAT3、CASP3、BDNF↑、PSD95↑、p-TrkB↑、Actin、p-Akt↑、mRNA↑、Ca2+↓、m-calpain↓、calpastatin↑、MDA↓、GSH↑、SOD↑、CAT↑、ROS↓、MFI↓、ACSL4↓、GPX4↑、SLC7A11↑、SYN |
银杏内酯B | SAMR1小鼠、SAMP8小鼠 | 20、30、40 mg/kg | GFAP、Iba-1、TNF-a、IL-1b、IL-6、SOD↑、GSH↑、MDA↓、NO↓、ROS↓、GPX4↑、Fe2+↓、TFR1、NCOA4、FTH1↑、Nrf2↑、RSL3、GAPDH、Lamin B1、DAPI |
Aβ1-42诱导的N2a细胞 | 100 μmol/L | FTH1↑、SPP1↓、ROS↓、SOD↑、MDA↓、SLC7A11↓、Psen2、Fn1↑、Ftl1↑、Syn1↓、Apom↓ | |
小檗碱 | 3×Tg-AD小鼠、WT小鼠 | 50 mg/kg | APP↓、Bace1↓、Aβ1-42↓、ADAM10↑、P-tau↓、Fe3+、Fe2+、FTH1、TFR、GSH↑、MDA↓、GPX4↑、SLC7A11↑、ACSL4↓、Nrf2、Keap1、4HNE↓、Fpn1、 |
番泻苷A | C57BL/6小鼠、APP/PS1小鼠 | 7.5、15、30 mg/kg | caspase-3↓、PARP-1↓、GSH↑、MDA↓、ROS、IL-1β↓、IL-6↓、TNF-α↓、TRAF6↓、p-P65↓ |
旋覆花内酯 | 5xFAD小鼠、C57BL6小鼠 | 20 mg/kg | TNF-α↓、PGE2↓、IL-10↑、Arg-1↑、iNOS↓、COX-2↓、GPx4、GSH↑、MDA↓、T-SOD↓、BACE1↓、Aβ↓、p-Tau↓、GFAP↓、Iba-1↓ |
圣草酚 | APP/PS1小鼠 | 50 mg/kg | Aβ↓、p-Tau↓、TfRC↓、FTH↓、Fpn↑、MDA↓、GPX4↑、ROS、mRNA↑、p-Nrf2↑、VDR、HO-1↑ |
表没食子儿茶素没食子酸酯 | DNL细胞、CHO细胞 | 1~10 μmol/L | TfR↑、β-actin、Aβ↓、holo-APP↓、IRPs、APP、sAPPα↑、mRNA |
仙茅苷 | ICR小鼠 | 50、100 mg/kg | GPX4↑、SLC7A11↓、MDA↓、Fe↓、GSH↑、GSH/GSSG↑、GAPDH、GCLM↑、GCLC↑、ROS↓、LIP、Aβ1-42↓、ACSL4↓、p-BECN1↑、p-Tau↓、FPN↑、STEAP3、DMT1 |
大黄酚 | SD大鼠(D-半乳糖造模) | 0.036 mg/mL | GPx↑、GSH↑、GPX4↑、ROS↓、GAPDH、Aβ |
麝香水提物 | HT22细胞 | 330 μg/mL、60 μg/mL | MDA↓、GSH↑、ROS↓、GPX4↑、SLC7A11↑、TFRC↓、Fpn1↑、FTH1↑、Fe2+、Nrf2、Keap1↓、HO-1、FTH1 |
茯苓酸 | SD大鼠(Aβ25-35诱导) | 50 mg/kg | Nrf2、SLC7A11、GPX4↑、GSH↑、MDA↓、Fe2+↓ |
Table 1 Experimental study on the treatment of Alzheimer's disease with effective ingredients of traditional Chinese medicine
有效成分 | 模型 | 剂量 | 靶点 |
---|---|---|---|
红景天苷 | SAMP8小鼠 | 30 mg/kg | Aβ1-42、铁沉积、MDA、IL-1β、IFN-γ、TNF-α、ACSL4、TFR1↓、GSH、SOD、IL-10、GPX4、SLC7A11、SLC3A2、FTH1、Fpn1、Nrf2、HO-1↑ |
Nrf2基因敲除小鼠、C57BL/6小鼠 | 50 mg/kg | MDA↓、SOD↑、GSH/GSSG↑、GPX4↑、SLC7A11↑、HO-1↑、ROS↓、Nrf2↑、Fe2+↓、PTGS2↓ | |
连翘酯苷A | APP/PS1小鼠 | 30 mg/kg | MDA↓、MMP,Aβ1-42、p-tau、NO↓、IL-4↑、IL-10↑、IL-1β↓、IL-6↓、Fe、GPX4↑、xCT↑、FTL↑、Fpn↑、DRD1↑、CREB↑、BDNF↑、TrkB↑、PI3K、p-AKT、GNAL↑、Adcy5↑、cAMP↑、p-Fyn↓、p-GSK-3β↑、Nrf2↑、TFRC↓、DMT1↓、FTH↑、Iba1↓、GFAP↓、TGF-β↑、MCP-1↓、ALOX5↓、CD33↓、iNOS↓、TNF-α↓、IKK↓ |
芍药苷 | C57BL/6小鼠、APP/PS1小鼠 | 10 mg/kg | Fe3+↓、SOD↑、MDA↓、JC-1↑、P53↓、STAT3、GPX4↑、GAPDH、ΔΨm |
淫羊藿苷 | APP/PS1小鼠、C57BL/6小鼠 | 5、10 mg/kg | MDA↓、SOD↑、MDM2、GSH-Px↑、LDH↓、GSH↑、caspase-3↓、Fe↓、p53↓、Aβ25-35↓、p-Tau |
何首乌苷 | APP/PS1小鼠、C57BL/6小鼠 | 60、120、180 mg/kg | Aβ↓、GSS、SOD1、SOD2、Prdx1、8-OHdG↓、Nrf2↑、Keap1↑、HO-1↑、NQO1↑、GCLC↑、GCLM↑、NLRP3↓、TXNIP↓、TXNRD1↓、iNOS↓、GPX4↑、xCT、GPX4↑、GPX1↑、FTH1↑、xCT↑、CD98↑、DMT1↓、ACSL4↓、NCOA4↓、FTH↓、FTL↓ |
远志皂苷元 | Aβ25-35诱导的PC12细胞 | 15、30、60、120、240 μmol/L | ACSL4↓、PEBP1↓、GPX4↑、ROS↓、MDA、GAPDH |
细叶远志皂苷 | C57BL/6小鼠 | 10 mg/kg | AKT、STAT3、CASP3、BDNF↑、PSD95↑、p-TrkB↑、Actin、p-Akt↑、mRNA↑、Ca2+↓、m-calpain↓、calpastatin↑、MDA↓、GSH↑、SOD↑、CAT↑、ROS↓、MFI↓、ACSL4↓、GPX4↑、SLC7A11↑、SYN |
银杏内酯B | SAMR1小鼠、SAMP8小鼠 | 20、30、40 mg/kg | GFAP、Iba-1、TNF-a、IL-1b、IL-6、SOD↑、GSH↑、MDA↓、NO↓、ROS↓、GPX4↑、Fe2+↓、TFR1、NCOA4、FTH1↑、Nrf2↑、RSL3、GAPDH、Lamin B1、DAPI |
Aβ1-42诱导的N2a细胞 | 100 μmol/L | FTH1↑、SPP1↓、ROS↓、SOD↑、MDA↓、SLC7A11↓、Psen2、Fn1↑、Ftl1↑、Syn1↓、Apom↓ | |
小檗碱 | 3×Tg-AD小鼠、WT小鼠 | 50 mg/kg | APP↓、Bace1↓、Aβ1-42↓、ADAM10↑、P-tau↓、Fe3+、Fe2+、FTH1、TFR、GSH↑、MDA↓、GPX4↑、SLC7A11↑、ACSL4↓、Nrf2、Keap1、4HNE↓、Fpn1、 |
番泻苷A | C57BL/6小鼠、APP/PS1小鼠 | 7.5、15、30 mg/kg | caspase-3↓、PARP-1↓、GSH↑、MDA↓、ROS、IL-1β↓、IL-6↓、TNF-α↓、TRAF6↓、p-P65↓ |
旋覆花内酯 | 5xFAD小鼠、C57BL6小鼠 | 20 mg/kg | TNF-α↓、PGE2↓、IL-10↑、Arg-1↑、iNOS↓、COX-2↓、GPx4、GSH↑、MDA↓、T-SOD↓、BACE1↓、Aβ↓、p-Tau↓、GFAP↓、Iba-1↓ |
圣草酚 | APP/PS1小鼠 | 50 mg/kg | Aβ↓、p-Tau↓、TfRC↓、FTH↓、Fpn↑、MDA↓、GPX4↑、ROS、mRNA↑、p-Nrf2↑、VDR、HO-1↑ |
表没食子儿茶素没食子酸酯 | DNL细胞、CHO细胞 | 1~10 μmol/L | TfR↑、β-actin、Aβ↓、holo-APP↓、IRPs、APP、sAPPα↑、mRNA |
仙茅苷 | ICR小鼠 | 50、100 mg/kg | GPX4↑、SLC7A11↓、MDA↓、Fe↓、GSH↑、GSH/GSSG↑、GAPDH、GCLM↑、GCLC↑、ROS↓、LIP、Aβ1-42↓、ACSL4↓、p-BECN1↑、p-Tau↓、FPN↑、STEAP3、DMT1 |
大黄酚 | SD大鼠(D-半乳糖造模) | 0.036 mg/mL | GPx↑、GSH↑、GPX4↑、ROS↓、GAPDH、Aβ |
麝香水提物 | HT22细胞 | 330 μg/mL、60 μg/mL | MDA↓、GSH↑、ROS↓、GPX4↑、SLC7A11↑、TFRC↓、Fpn1↑、FTH1↑、Fe2+、Nrf2、Keap1↓、HO-1、FTH1 |
茯苓酸 | SD大鼠(Aβ25-35诱导) | 50 mg/kg | Nrf2、SLC7A11、GPX4↑、GSH↑、MDA↓、Fe2+↓ |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
李燕新,吕占云,李维,等. 铁死亡相关蛋白在AD小鼠海马中的表达[J]. 中国神经精神疾病杂志,2018,44(12):727-731. DOI:10.3969/j.issn.1002-0152.2018.12.008.
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
[38] |
|
[39] |
|
[40] |
|
[41] |
|
[42] |
|
[43] |
|
[44] |
|
[45] |
|
[46] |
|
[47] |
|
[48] |
|
[49] |
|
[50] |
|
[51] |
|
[52] |
|
[53] |
|
[54] |
|
[55] |
|
[56] |
|
[57] |
|
[58] |
|
[59] |
|
[60] |
|
[61] |
|
[62] |
|
[63] |
|
[64] |
|
[65] |
|
[66] |
|
[67] |
|
[68] |
|
[69] |
|
[70] |
|
[71] |
|
[72] |
|
[73] |
|
[74] |
|
[75] |
|
[76] |
|
[77] |
|
[78] |
樊赟,窦润鹏,胡久略,等. 茯苓酸通过Nrf2/SLC7A11/GPX4信号通路调控铁死亡改善阿尔茨海默病大鼠认知障碍的研究[J]. 中国全科医学,2024,27(2):177-183. DOI:10.12114/j.issn.1007-9572.2023.0326.
|
[79] |
|
[80] |
刘珊,贺小平,赵炎,等. 淫黄葛合剂对APP/PS1 HAMP-/-小鼠认知功能和铁死亡氨基酸代谢通路的影响[J]. 中国病理生理杂志,2024,40(3):502-510. DOI:10.3969/j.issn.1000-4718.2024.03.014.
|
[81] |
|
[1] | TIAN Chen, LIU Jianing, TIAN Jinhui, GE Long. Living Systematic Reviews: Methods and Processes for Development [J]. Chinese General Practice, 2025, 28(30): 3853-3860. |
[2] | WANG Tingting, TANG Yong, ZHANG Wenke, LI Zhigang. Research Progress on Exercise Intervention of Hyperuricemia [J]. Chinese General Practice, 2025, 28(30): 3841-3846. |
[3] | ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping. Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(27): 3466-3472. |
[4] | HUANG Yulin, WANG Haoyun, LI Yanmei, XIAO Xueying. Symptom Clusters in Gastric Cancer Patients Receiving Chemotherapy: a Scoping Review [J]. Chinese General Practice, 2025, 28(26): 3338-3344. |
[5] | LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong. Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment [J]. Chinese General Practice, 2025, 28(24): 3072-3078. |
[6] | LI Miaoxiu, ZHU Bowen, KONG Lingjun, FANG Min. Progress in Research on Clinical Assessment Tools for Conservative Treatment of Adolescent Idiopathic Scoliosis [J]. Chinese General Practice, 2025, 28(24): 3079-3088. |
[7] | XIAO Yao, WAN Jun. Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants [J]. Chinese General Practice, 2025, 28(24): 3066-3071. |
[8] | RUAN Wanbai, LI Junfeng, YIN Yanmei, PENG Lei, ZHU Kexiang. Research Progress of Targeted Therapy and Immunotherapy for Pancreatic Cancer [J]. Chinese General Practice, 2025, 28(23): 2950-2960. |
[9] | ZHOU Lianpeng, LI Weifeng, DONG Xingang, WANG Xiaoyuan. Research Progress on the Role of Copper Homeostasis Regulation Mechanism in Cognition Disorder [J]. Chinese General Practice, 2025, 28(23): 2941-2949. |
[10] | DONG Haocheng, HAO Xiao, AN Dong, LI Haohan, LI Shuren. Research Progress of Heart Failure with Supra-normal Ejection Fraction [J]. Chinese General Practice, 2025, 28(21): 2692-2696. |
[11] | DU Qiongliang, LIN Bailang, GUO Honghua. Research Progress and Implications of Group Well-child Care [J]. Chinese General Practice, 2025, 28(21): 2672-2678. |
[12] | WEN Yongxia, SUN Hai, CHEN Xiaoju, CAI Wanjing, LI Shuni, GUO Honghua. A Systematic Review of the Assessment Tools for Maternal Psychological Birth Trauma [J]. Chinese General Practice, 2025, 28(20): 2555-2561. |
[13] | CHU Tianyu, GU Yan. Carotid Artery Calcification Features in Plaque Stability and Clinical Events [J]. Chinese General Practice, 2025, 28(18): 2247-2252. |
[14] | ZHU Ziyi, HE Guixin, QIN Weibin, SONG Hui, ZHANG Liwen, TANG Weizhi, YANG Feifei, LIU Lingyun, OUYANG Bin. Research Progress of Mitochondrial Autophagy in Improving Myocardial Fibrosis after Myocardial Infarction and Intervention of Traditional Chinese Medicine [J]. Chinese General Practice, 2025, 28(18): 2294-2300. |
[15] | TAN Wenbin, LI Jia, LIU Mingyu, LU Yongxin, CHENG Yaxin. Research Progress on the Influence of Nervous System Diseases and Related Therapeutic Drugs on Osteoporosis [J]. Chinese General Practice, 2025, 28(17): 2092-2100. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||